Sun Jun 29 08:06:17 UTC 2025: Okay, here’s a summary of the text and a rewritten news article based on it:
**Summary:**
Indian Group Captain Shubhanshu Shukla has begun conducting research aboard the International Space Station (ISS) as part of the Axiom-4 mission. He’s involved in several experiments, including the Myogenesis study (investigating muscle degradation in space), and Cerebral Hemodynamics study which looks at blood circulation in the brain in microgravity conditions. These experiments are significant for both space exploration and potential advancements in terrestrial medicine. ISRO has shortlisted seven microgravity research experiments proposed by Indian (PIs) from various national R&D laboratories and academic institutions which Group Captain Shukla would be conducting during his 14-day stay at the ISS. The mission is a collaborative effort with international partners and includes a wide range of scientific studies.
**News Article:**
**Indian Astronaut Begins Groundbreaking Research on ISS**
**Bengaluru, June 29, 2025** – Group Captain Shubhanshu Shukla, call sign “Shux”, has commenced his research activities aboard the International Space Station (ISS), marking a significant milestone for India’s space program. Aboard the orbiting laboratory as part of the Axiom-4 mission, Group Captain Shukla is diving into a series of experiments designed to unlock crucial insights into human physiology in microgravity.
According to Axiom Space, the crew has seamlessly transitioned into their mission, prioritizing hands-on research. Group Captain Shukla has already dedicated time to the Myogenesis experiment within the Life Sciences Glovebox (LSG). This study, proposed by Bengaluru’s Institute of Stem Cell Science and Regenerative Medicine (InStem), aims to identify the biological pathways behind skeletal muscle degradation in space, which is a major challenge for astronauts. Researchers hope to develop targeted therapies that could not only protect space travelers but also aid people suffering from muscle-degenerative diseases on Earth.
“This mission represents a major step forward for India’s microgravity research program,” said a representative from ISRO. “The experience gained through these experiments is expected to nurture a microgravity research ecosystem in India, resulting in the induction of advanced microgravity experiments in various disciplines in the Indian space programme.”
In addition to Myogenesis, Group Captain Shukla is also participating in the Cerebral Hemodynamics study, which uses ultrasound technology to explore how blood circulates in the brain under microgravity conditions. Results from this study could provide invaluable information for understanding cardiovascular adaptation in space and potentially lead to improved diagnostics and treatments for conditions like stroke and hypertension on Earth.
The Axiom-4 mission encompasses approximately 60 scientific studies and activities representing 31 countries, highlighting the collaborative nature of space exploration. ISRO has shortlisted seven microgravity research experiments proposed by Indian (PIs) from various national R&D laboratories and academic institutions which Group Captain Shukla would be conducting during his 14-day stay at the ISS. ISRO and NASA will also be participating in five joint science investigations and two in-orbit STEM demonstrations.
This mission not only demonstrates India’s growing capabilities in space science but also promises to yield breakthroughs that will benefit both space travelers and people on Earth.
First Piper 